Level 3 · Retrospective cohort / observational
Anti-aging
Mechanism
Media-cited
Bottom line
First human trial showing HBOT-induced reversal of two hallmarks of aging — cited extensively in longevity media. Mechanism remains debated.
Outcome
Telomere length +20–38% in multiple cell types; senescent T-cell populations reduced by up to 37%.
Conditions studied
- Longevity & Anti-Aging — Early single-arm trial — Novel finding, replication pending
Full citation
Hachmo Y, Hadanny A, Abu Hamed R, et al. HBOT Increases Telomere Length and Decreases Immunosenescence in Isolated Blood Cells. Aging. 2020. doi:10.18632/aging.202188.
View on PubMed (PMID 33206062) →
Related studies
- The Hyperoxic-Hypoxic Paradox (2020, Level 5)